Darbepoetin in chronic kidney disease and dialysis patients; an updated review of outcomes
Individuals with chronic renal failure in stage three and after demonstrate anemia as a frequent complication. Although target hemoglobin levels remain debatable in pre-dialysis and dialysis patients, correction of anemia with erythropoiesis-stimulating agents (ESAs) has resulted in reduced need for...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Society of Diabetic Nephropathy Prevention
2020-05-01
|
| Σειρά: | Journal of Nephropharmacology |
| Θέματα: | |
| Διαθέσιμο Online: | https://jnephropharmacology.com/PDF/npj-2295 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|